News

Enzymit, a synthetic biology company, raises $10 million Series A led by Grove Ventures and Khosla Ventures for cell-free bio-production technology that aims to make bioproduction faster, simpler, cost-effective, and scalable. 

25 September 2024

SKYOPS and Airwayz form a strategic partnership to capitalize on European regulatory changes.

5 June 2023

Skip to content